Insider Title Company Date Price Return Shares Value
Kupiec James William Chief Clinical Dev CASSAVA SCIENCES INC (SAVA) 2022-08-23 $17.46 68.7% 3,500 $61,100
Return Profit / (loss) Cost
Total 68.7% $41,975 $61,100